Announcements

Silence Therapeutics plc filed a current report on Form 8-K on August 12, 2026, disclosing that it entered into an underwriting agreement on August 11, 2026, to sell American Depositary Shares in an underwritten public offering priced at $13.50 per ADS.

Cerebras Systems Inc. submitted its Form 10-Q for the quarterly period ended June 30, 2026, filed with the U.S. Securities and Exchange Commission and disclosing share counts, company structure, and operational context for the AI compute company.

GMR Solutions Inc. (NYSE:GMRS) filed its Form 10-Q for the quarterly period ended June 30, 2026 with the Securities and Exchange Commission, disclosing condensed consolidated financial statements and related notes as of that date.

M Evo Global Acquisition Corp II filed its quarterly report on Form 10-Q for the quarter ended June 30, 2026, disclosing results following the completion of its Initial Public Offering earlier in the year.

Churchill Capital Corp XII, a Cayman Islands exempted company and blank-check SPAC, filed its quarterly report on Form 10-Q with the SEC on August 12, 2026, covering the period ended June 30, 2026.

Silverbox Corp IV filed its Form 10-Q for the quarter ended June 30, 2026 with the U.S. Securities and Exchange Commission, reporting net income of $1,655,077 for the three-month period and disclosing $217,134,228 held in its Trust Account.

Viking Acquisition Corp. I filed its quarterly report on Form 10-Q for the quarter ended June 30, 2026 with the U.S. Securities and Exchange Commission on August 12, 2026, disclosing financial results for its first half of operations since inception on July 24, 2025.